| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | $0.6B | $0.5B | $0.5B |
| SG&A Expense | — | $0.7B | — |
| Operating Income | $-1.0B | $4.2B | $-1.4B |
| Net Income | $-0.2B | $4.3B | $-0.8B |
| EPS (Basic) | $-0.24 | $5.55 | — |
| EPS (Diluted) | $-0.24 | $5.23 | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|
| Total Assets | $5.4B | $7.2B | $2.6B |
| Current Assets | $5.0B | $6.7B | $2.1B |
| Cash & Equivalents | $2.7B | $6.5B | $2.1B |
| Total Liabilities | $0.2B | $0.8B | $0.5B |
| Current Liabilities | $0.1B | $0.3B | $0.2B |
| Stockholders' Equity | $4.7B | $6.0B | $1.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|
| Operating Cash Flow | $-0.8B | $-0.8B | $-0.7B |
| Investing Cash Flow | $-1.8B | $5.2B | $0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.2B | $0.4B | $0.3B |